Moreover, a clinical study revealed that CRC patients with high expression of the TH17 cluster and a high density of IL-17-positive cells in situ may have a shorter disease-free survival time and early relapse after primary CRC tumor surgical resection (24). The gene discussed is IL17A; the disease is neoplasm.